Amphotericin B-induced hepatorenal failure in cystic fibrosis
Authors:
- 3 May 2002
- journal article
- case report
- Published by Wiley in Pediatric Pulmonology
- Vol. 33 (6) , 497-500
Abstract
Although nephrotoxicity is a common and well-recognized side effect of amphotericin B, hepatotoxicity is rare. We report on a 9-year-old girl with cystic fibrosis who developed fulminant renal and hepatic dysfunction following a short course of intravenous amphotericin B for a suspected aspergillus infection, although she did not have clinical evidence of invasive aspergillosis. The toxicity became apparent after changing to liposomal amphotericin. This association of renal and hepatotoxicity with liposomal amphotericin B has not previously been reported in children.Keywords
This publication has 14 references indexed in Scilit:
- A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosisThe Journal of Pediatrics, 1995
- Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis.Thorax, 1994
- Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosisPediatric Pulmonology, 1994
- Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatmentThe Lancet, 1991
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Reversal of cancer chemotherapeutic resistance by amphotericin B—A broad phase I–II pilot studyEuropean Journal of Cancer and Clinical Oncology, 1987
- Permeability Control in Animal Cells by Polyenes: a PossibilityAntimicrobial Agents and Chemotherapy, 1973
- Potentiation of Rifampicin and 5-Fluorocytosine as Antifungal Antibiotics by Amphotericin BProceedings of the National Academy of Sciences, 1972
- Pharmacology, Toxicity, and Therapeutic Usefulness of Amphotericin BJAMA, 1966
- FATAL TOXIC REACTION TO AMPHOTERICIN B IN CRYPTOCOCCAL MENINGO-ENCEPHALITISAnnals of Internal Medicine, 1960